[fa icon="calendar'] Feb 15, 2013 11:34:20 AM / by Admin posted in Blog, Critical Path Opportunity, Generic nasal spray suspsension, Ingredient-Specific Particle Sizing, particle sizing, Pharmaceutical
On February 12th, Tracey Safran, Senior Account Manager and Oksana Olkhovyk, Senior Scientist at Gateway Analytical hosted a webinar for generic drug manufacturers of nasal spray suspensions discussing how the method of Ingredient-Specific Particle Sizing (ISPS) using Raman Chemical Imaging (RCI) developed by Gateway Analytical, can address the critical path opportunity (CPO) by providing the accurate and precise drug particle size measurement to demonstrate bioequivalence.
[fa icon="calendar'] Jan 22, 2013 3:27:15 PM / by Admin posted in bioequivalence, Blog, cGMP laboratory, Critical Path Opportunity, Generic nasal spray suspsension, Ingredient-Specific Particle Sizsing, Pharmaceutical, Pharmaceutical Webinars, Raman chemical imaging, Recorded Webinars
[fa icon="phone"] +1 724-443-1900
[fa icon="envelope"] info@gatewayanalytical.com
[fa icon="home"] 2009 Kramer Road; Gibsonia, PA 15044 USA